1. Home
  2. LNN vs ATAI Comparison

LNN vs ATAI Comparison

Compare LNN & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$124.39

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$3.93

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNN
ATAI
Founded
1954
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1988
2021

Fundamental Metrics

Financial Performance
Metric
LNN
ATAI
Price
$124.39
$3.93
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$128.00
$13.86
AVG Volume (30 Days)
117.1K
3.9M
Earning Date
01-08-2026
03-16-2026
Dividend Yield
1.19%
N/A
EPS Growth
8.56
N/A
EPS
6.75
N/A
Revenue
$665,905,000.00
$3,018,000.00
Revenue This Year
N/A
$962.66
Revenue Next Year
$5.91
N/A
P/E Ratio
$18.48
N/A
Revenue Growth
8.81
811.78
52 Week Low
$106.10
$1.15
52 Week High
$150.96
$6.75

Technical Indicators

Market Signals
Indicator
LNN
ATAI
Relative Strength Index (RSI) 54.48 48.45
Support Level $122.39 $3.50
Resistance Level $127.13 $4.17
Average True Range (ATR) 3.92 0.22
MACD 0.01 0.04
Stochastic Oscillator 67.19 63.44

Price Performance

Historical Comparison
LNN
ATAI

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About ATAI ATAI Life Sciences N.V.

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

Share on Social Networks: